[Ip-health] MPP and Unitaid Symposium at the 22nd International AIDS Conference - Tuesday 24 July, 18:30-20:30

Sophie Thievenaz sthievenaz at medicinespatentpool.org
Fri Jul 20 06:00:09 PDT 2018

The Medicines Patent Pool (MPP) and Unitaid are honoured to invite you to a Satellite Symposium during the 22nd International AIDS Conference.

Meet the manufacturers of HIV and HCV treatments: challenges and opportunities for treatment scale-up

Manufacturers, licensees of the MPP, will discuss the new adult and paediatric formulations they are currently developing or have recently introduced; roll-out plans and timelines; existing challenges and opportunities; and market trends. An interactive Q&A session will follow.

Tuesday 24 July 2018, from 18:30 to 20:30

Emerald room
RAI Amsterdam Convention Centre
Europaplein 24
1078 GZ Amsterdam

All conference participants are welcome to join.

Light refreshments will be served 30 minutes before the event.

To register: https://www.eventbrite.co.uk/e/meet-the-manufacturers-of-hiv-and-hcv-treatments-challenges-and-opportunities-for-treatment-scale-up-registration-47220607107?aff=escb&utm-source=cp&utm-term=listing&utm-campaign=social&utm-medium=discovery&utm-content=attendeeshare

Download the Invitation:

Download full MPP programme @ AIDS 2018:



Opening remarks by co-chairs
Charles Gore, Executive Director, Medicines Patent Pool (MPP) and Alexandra Volgina, Program Manager, GNP+

Introductory presentations

“From pipelines to frontlines and the role of manufacturers: challenges and opportunities in facilitating the introduction of new HIV and HCV treatments in low- and middle-income countries” – Robert Matiru, Director of Operations, Unitaid
“Accelerating access to new WHO recommended generic medicines and formulations” – Esteban Burrone, Head of Policy, MPP and Aastha Gupta, Head of Business Development a.i., MPP
“Transition to new treatments and formulations” – Françoise Renaud, Department of HIV/AIDS, World Health Organization


Panel discussion moderated by co-chairs

Arvind Kanda, Senior Vice President – Head HIV and Infectious Diseases, API, South Africa and Sub-Saharan Africa, Mylan
Balaji UD, Senior Director, Global HIV/AIDS Initiatives, Emcure Pharmaceuticals
Chandrakanth Chereddi, Executive Director & Head – Generics FDF Division, Laurus Labs
Jos Perriëns, Strategic Advisor Access Markets, Hetero Corporate
Shailesh Pednekar, Senior Vice President – International Business, Macleods
Umesh K, Vice President and Business Unit Head, Global Anti-Virals, Aurobindo Pharma

Q&A session
Closing remarks

Sophie Thievenaz | Communications Manager | Medicines Patent Pool
Tel: +41 22 533 5063 | Mob: +41 79 870 85 52
E-mail: sthievenaz at medicinespatentpool.org<mailto:sthievenaz at medicinespatentpool.org>

More information about the Ip-health mailing list